Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary hyperoxaluria.

Literature DB >> 23944302

Primary hyperoxaluria.

Pierre Cochat¹, Gill Rumsby.

Abstract

Entities: Disease

Mesh：

Substances：
Calcium Oxalate

Year: 2013 PMID： 23944302 DOI： 10.1056/NEJMra1301564

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

153 in total

1. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

Authors: Abigail Liebow; Xingsheng Li; Timothy Racie; Julia Hettinger; Brian R Bettencourt; Nader Najafian; Patrick Haslett; Kevin Fitzgerald; Ross P Holmes; David Erbe; William Querbes; John Knight
Journal: J Am Soc Nephrol Date: 2016-07-18 Impact factor: 10.121

2. Bone oxaloma-a localized manifestation of bone oxalosis.

Authors: Eun Ji Choi; Choong Guen Chee; Wanlim Kim; Joon Seon Song; Hye Won Chung
Journal: Skeletal Radiol Date: 2019-11-25 Impact factor: 2.199

3. Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.

Authors: Ada Ventzke; Markus Feldkötter; Andrew Wei; Jutta Becker; Bodo B Beck; Bernd Hoppe
Journal: Pediatr Nephrol Date: 2017-07-15 Impact factor: 3.714

4. Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

Authors: Katharina Hopp; Andrea G Cogal; Eric J Bergstralh; Barbara M Seide; Julie B Olson; Alicia M Meek; John C Lieske; Dawn S Milliner; Peter C Harris
Journal: J Am Soc Nephrol Date: 2015-02-02 Impact factor: 10.121

5. Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors: Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal: J Clin Invest Date: 2019-07-30 Impact factor: 14.808

Primary hyperoxaluria.

1. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

2. Bone oxaloma-a localized manifestation of bone oxalosis.

3. Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.

4. Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

5. Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

6. Paraplegia as a presentation of primary hyperoxaluria.

Review 7. Primary disease recurrence—effects on paediatric renal transplantation outcomes.

8. HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.

Review 9. Oxalate, inflammasome, and progression of kidney disease.

10. Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.